Page 5 of 13
Marie Mazur Appointed Chair of PharmaJet Board of Directors
GOLDEN, Colo. — June 6, 2023 – PharmaJet® a company engineering Precision Delivery Systems™ that overcome the challenges of vaccines and pharmaceuticals delivery today announced that Marie Mazur, PharmD, has been appointed Chair of the Board of Directors. She replaces Ron Lowy who had chaired the Board since 2011.
Tags: Other
June 2, 2023
WHO launching Polio Eradication Campaign in Pakistan using PharmaJet Precision Delivery System
GOLDEN, Colo. — May 23, 2023 — PharmaJet®, a company engineering precision delivery systems that overcome the challenges of vaccine delivery, today announced their support for the World Health Organization’s (WHO) polio eradication campaigns in Pakistan starting in May 2023. PharmaJet is providing an additional 5 million syringes to the WHO for a supplemental immunization activity (SIA) campaign which will be conducted in two phases in the Southern districts of Khyber Pakhtunkhwa (KP) Province located in the north-west region of Pakistan, and in the Quetta Block located in Northern Balochistan Province near the Pakistan-Afghanistan border.
May 16, 2023
PharmaJet Announces Appointment of Nathalie Landry as Chief Scientific Officer.
GOLDEN, Colo. — May 2, 2023 – PharmaJet ® a company engineering Precision Delivery Systems™ that may overcome the challenges of vaccines and pharmaceuticals delivery today announced that Nathalie Landry, has been appointed Chief Scientific Officer.
Tags: Other
April 19, 2023
PharmaJet announces U.S. Government award expansion to clinically assess a DNA Vaccine combined with its Systems.
GOLDEN, Colo. — April 18, 2023 —PharmaJet®, a company engineering Precision Delivery Systems™ (PDS) that overcome the challenges of vaccine delivery, today announced that it received a scope expansion and 3-year extension of its multi-year agreement with the Joint Science and Technology Office of the U.S. Defense Threat Reduction Agency (DTRA). The expansion award, worth over $4 million, will be used to further advance the clinical assessment of its Venezuelan Equine Encephalitis Virus (VEEV) DNA candidate vaccine in combination with either Tropis Intradermal (ID) or Stratis Intramuscular (IM) Systems.
Tags: DNA, Nucleic Acid, Stratis, Tropis, Tropis/Stratis, VEEV
April 10, 2023
Gennova applies for Covid-19 booster emergency use authorisation in India
Gennova Biopharmaceuticals has applied for an emergency use authorisation (EUA) from the Drug Controller General of India (DCGI) for its mRNA-based Omicron-specific Covid-19 booster vaccine.
April 4, 2023
Genoskin and PharmaJet Announce Strategic Research Partnership to Advance Precision Vaccine Delivery
Genoskin, a leading Franco-American TechBio company specializing in bio-stabilized immunocompetent human skin platforms, and PharmaJet, an innovative provider of Precision Delivery Systems (PDS), announce a strategic research partnership during the World Vaccine Congress.
April 1, 2023
Needle-Free Precision Delivery Systems boost immune response of DNA vaccines: Comprehensive scientific literature review
GOLDEN, Colo. — April 4, 2023 — Results of a comprehensive review of published scientific literature comparing data associated with various DNA vaccine delivery methods will be presented at the World Vaccine Congress 2023 on April 5, 2023 at 5:10 pm ET.
Tags: COVID-19, DNA, Events, Stratis, Tropis, Tropis/Stratis
March 30, 2023
PharmaJet partner Gennova Biopharmaceuticals seeks Emergency Use Authorization in India for the First Needle-free mRNA Vaccine Omicron Booster.
GOLDEN, Colo. — April 3, 2023 – Following completion of Phase II/III study, PharmaJet partner Gennova Biopharmaceuticals Limited has submitted data for its mRNA-based Omicron specific Covid-19 booster shot for Emergency Use Authorization (EUA) to the office of the drug controller General of India (DCGI). The submission corresponds with an increase in COVID-19 cases in India1 and is the first booster in India targeted specifically for the Omicron variant. The vaccine, GEMCOVAC-OM, will be delivered exclusively with the PharmaJet Tropis Precision Delivery System (PDS).
March 29, 2023
Adapting to the changing face of drug delivery
Drug delivery is constantly changing – and the materials to support new applications must continue to evolve as well. Meeting current and future needs requires innovative materials to overcome age-old familiar hurdles and Covestro experts are leading the way.
Tags: DNA, Stratis, Tropis, Tropis/Stratis
March 9, 2023
PharmaJet announces clinical results from Scancell’s COVID-19 DNA vaccine study exclusively administered with their needle-free precision delivery systems.
GOLDEN, Colo. — March 21, 2023 — PharmaJet®, a company engineering precision delivery systems that may overcome the challenges of nucleic acid vaccine delivery, today announced that its partner, Scancell, a developer of novel immunotherapies for the treatment of cancer and infectious diseases, reported positive results from their Phase 1 COVIDITY clinical trial. The trial was conducted at the University of Cape Town Lung Institute in South Africa to assess the safety and immunogenicity of their COVID-19 DNA candidate vaccines, SCOV1 and SCOV2. The vaccines were exclusively administered using the PharmaJet Tropis® and Stratis® needle-free precision delivery systems.
Tags: COVID-19, DNA, Stratis, Tropis, Tropis/Stratis
March 8, 2023
PharmaJet, Nigeria’s National Primary Health Care Development Agency and Health-focused Consortium Launch Assessment of the PharmaJet Tropis Vaccine Delivery System
GOLDEN, Colo. — March 7, 2023 — PharmaJet® , a company that engineers precision delivery systems that overcome the challenges of vaccine delivery, today announced the December 2022, in-country kickoff of a study to evaluate the impact of intradermal (ID) vaccine administration using their Tropis® ID Needle-free Injection System (NFIS). PharmaJet and co-investigators from the National Primary Health Care Development Agency (NPHCDA), Jhpiego, PATH and the Sydani Group met in Lagos Nigeria and have finalized the study design, outlined the timelines, protocol, and tools for the study.
March 1, 2023
Improved DNA Vaccine Delivery with Needle-Free Injection Systems
2023 | Ledesma-Feliciano, C
Tags: COVID-19, Dengue, DNA, Hantaviruses, HIV, Influenza, Pox, Tropis/Stratis, VEEV, Zika
February 23, 2023
Review highlights growing evidence that PharmaJet’s precision delivery devices improve nucleic acid vaccine performance.
GOLDEN, Colo. — February 23, 2023 — In a review article recently published in Vaccines Journal (MDPI), Dr. Carmen Ledesma-Feliciano, Scientific Affairs Manager at PharmaJet, referencing over 25 studies, discusses multiple injection delivery methods including PharmaJet’s needle-free precision delivery systems, which enhance the clinical performance of DNA-based vaccines.
Tags: COVID-19, DNA, Stratis, Tropis, Tropis/Stratis, Zydus
February 22, 2023
Sitemap
Sitemap WebpagesPharmaJet Instructions for Use: Previous VersionsSite DisclaimerPrivacy Statement (BR)Privacy Statement (ZA)Privacy Statement (AU)Privacy Statement (CA)Privacy Statement (US)Privacy Statement (UK)Privacy Statement (EU)Cookie Policy (BR)Cookie Policy (AU)Cookie Policy (EU)Cookie Policy (UK)Opt-out preferencesCookie Policy (CA)Cookie Policy (ZA)Infectious DiseaseIntradermalPresentationsSearch ResultsOncologyPartner With UsOur BlogsEventsStratis® Educational VideoTropis® Educational VideoRegulatory ClearancesNeedle-FreeNucleic Acid VaccinesCOVID-19Needleless Flu ShotStratisPipelineGlobal ImpactContactTerms and ConditionsDMCA PolicyAboutPress CoverageTropisPublicationsNews ReleasesFAQsHomeNews...
October 28, 2025
PharmaJet Tropis ID: A proven solution for intradermal (ID) delivery – overcoming the challenges made evident by the Monkeypox (mpox) vaccine shortage.
Last summer, when monkeypox (mpox, in 2024) was declared a national1 and global health emergency, a shortage of the mpox vaccine was announced2. In August 2022, the US Food and Drug Administration (USFDA) authorized3 reduced dose (0.1 mL) intradermal (ID) delivery of mpox vaccine to address the supply gaps and extend limited stocks. The EU followed with their own recommendations on intradermal delivery. 4
January 12, 2023
PharmaJet Partner Immunomic Therapeutics receives FDA Fast Track Designation for pDNA Vaccine for Skin Cancer
GOLDEN, Colo. — December 13, 2022 — PharmaJet®, a company that engineers precision delivery systems that overcome the challenges of vaccine and pharmaceutical companies, today announced that their partner Immunomic Therapeutics received FDA fast track designation (FTD) for the clinical study of their plasmid DNA vaccine ITI-3000 in patients with Merkel cell carcinoma (MCC), a rare but aggressive form of skin cancer. Enrollment is in progress for the phase 1 study that exclusively uses the PharmaJet Stratis Needle-free Injection System (NFIS).
December 8, 2022
PharmaJet Receives NIH Grant to Evaluate use of Needle-free Intradermal Delivery for HPV Immunization
GOLDEN, Colo. — November 29, 2022 — PharmaJet®, a company that has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced they received an $800,000+ direct to Phase II grant from the National Institutes of Health (NIH), to evaluate the immunogenicity of intradermal administration of human papillomavirus virus (HPV) vaccine using their Tropis intradermal (ID) Needle-free Injection System (NFIS). The study will compare Tropis intradermal delivery against traditional needle and syringe (N/S) intramuscular administration.
November 17, 2022
PharmaJet Needle-free System selected to deliver Intradermal Polio vaccine in Nigerian Campaign
GOLDEN, Colo. — November 8, 2022 — PharmaJet®, a company that has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced that their PharmaJet Tropis® Needle-free Injection System (NFIS) will be used in a door-to-door immunization campaign aimed at reducing the outbreak of circulating mutant poliovirus Type 2 (cMPV2). The initial pilot, targeting thousands of children under 5 years of age in the Sokoto North local government area (LGA) of Nigeria, will begin on November 5, 2022 and run for 4 days.
November 3, 2022
On the Horizon, Needle-Free Vaccines could Offer Better Protection and Access
Everyone is tired of being jabbed, but today, that’s the predominant option for vaccination. In the near future, however, the painful jab and muscle soreness that persists for days will be eliminated by needleless vaccines that – at least in some cases – provide more robust protection.
Tags: COVID-19, Polio, Stratis, Tropis
November 1, 2022
On World Polio Day 2022, PharmaJet announces $1.5 million grant from USAID to evaluate use of needle-free delivery in routine polio immunization
GOLDEN, Colo. — October 24, 2022 — PharmaJet®, a company that has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced they received a multi-year, $1.5 million grant from the United States Agency for International Development (USAID), to evaluate the impact of intradermal (ID) vaccine administration using their Tropis® Needle-free Injection System (NFIS).
October 20, 2022
Page 5 of 13